�›�@Šw�Z‹‹�H‚Ö
. ‘�މ–b –O˜aމ–b ƒgƒ‰ƒ“ƒXމ–b ƒRƒŒƒXƒeƒ��[ƒ‹
�¢ŠE•ÛŒ’‹@�\WHO‚Ì–Ú•W—Ê 15-30% 10%–¢–ž 1%–¢–ž 300mg/“ú–¢–ž
•Ä�‘�S‘Ÿ‹¦‰ïAHA‘å�l‚Ì–Ú•W—Ê . 7%–¢–ž 1%–¢–ž 300mg/“ú–¢–ž
•Ä�‘�S‘Ÿ‹¦‰ïAHA4-18�΂̖ڕW—Ê 25-35% �­‚È‚­ �­‚È‚­ .
•Ä�‘Šw�Z‹‹�H‚ÌŠî�€ 30%ˆÈ‰º 10%–¢–ž . �­‚È‚­
‰p�‘Šw�Z‹‹�H‚ÌŠî�€ 35%ˆÈ‰º 11%ˆÈ‰º 2%ˆÈ‰º .
“ú–{�l‚Ì�HŽ–�ÛŽæŠî�€ . . . .
30-69�Î�@’j�« 20-25% 4.5-7.0% . 750mg/“ú–¢–ž
30-69�Î�@�—�« 20-25% 4.5-7.0% . 600mg/“ú–¢–ž
18-29�Î�@’j�« 20-30% 4.5-7.0% . 750mg/“ú–¢–ž
18-29�Î�@�—�« 20-30 4.5-7.0% . 600mg/“ú–¢–ž
6-17�Î ’j�« 20-30% . . .
6-17�Î �—�« 20-30% . . .
“Œ‹ž“sŠw�Z‹‹�H‚ÌŠî�€ 25-30% . . .